Market Movers: Forma (FMTX) Climbs 9.09% to Close at $9.84 August 4

Equities Staff  |

Today, Forma Therapeutics Holdings Inc (NASDAQ:FMTX) was up $0.82 to finish the day Thursday at $9.84.

The company began the day at $9.08 and shares fluctuated between $9.84 and $8.82 with 266,903 shares trading hands.

Forma is averaging 425,906 shares traded over the last 30 days. They have shed 36.57% YTD.

Forma anticipates its next earnings on 2022-08-09.

For technical charts, analysis, and more on Forma visit the company profile.

About Forma Therapeutics Holdings Inc

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Its R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Its work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit.

To get more information on Forma Therapeutics Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: Forma Therapeutics Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

China, Taiwan and the Boycott
An Easy Way to Profit Off One of Today’s Strongest Sectors
The Future of Smartphones is Still Unfolding: Jeff Kagan
These Stocks are Sending a Signal (Like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan



Market Movers

Sponsored Financial Content